Pulmonary Eosinophilia

1998 ◽  
pp. 137-138
2012 ◽  
Vol 61 (2) ◽  
pp. 381-384 ◽  
Author(s):  
Sayantan Ray ◽  
Supratip Kundu ◽  
Manas Goswami ◽  
Subhasis Maitra

1977 ◽  
Vol 71 ◽  
pp. 115-122 ◽  
Author(s):  
W.G. Middleton ◽  
I.C. Paterson ◽  
I.W.B. Grant ◽  
A.C. Douglas

1987 ◽  
Vol 80 (2) ◽  
pp. 120-121 ◽  
Author(s):  
K C Flint ◽  
N Mci Johnson

2004 ◽  
Vol 39 (8) ◽  
pp. 1123-1128 ◽  
Author(s):  
A. K. Boggild ◽  
J. S. Keystone ◽  
K. C. Kain

2016 ◽  
Vol 2016 ◽  
pp. 1-4 ◽  
Author(s):  
Mathieu D. Saint-Pierre ◽  
Onofre Moran-Mendoza

Pulmonary eosinophilia (PE) can be found in very diverse pathological processes. Several medications have also been associated with this entity. Acetaminophen is a medication commonly used in multiple different drug formulations, many of which are available without a prescription. It has however been associated with pulmonary eosinophilia (eosinophilic pneumonia) in a few cases in Japan. We describe the case of a 68-year-old Caucasian female who presented with new persistent dry cough and dyspnea on exertion after she started using up to 4 grams of acetaminophen on a daily basis. Chest imaging revealed peripheral lower lung zone ground glass and reticular opacities, and increased eosinophils were present on bronchoalveolar lavage (BAL). The patient’s symptoms markedly improved upon acetaminophen cessation, and significantly decreased eosinophils were seen on repeat BAL. To our knowledge, this is the first case of likely acetaminophen-induced pulmonary eosinophilia reported outside Japan.


Thorax ◽  
1983 ◽  
Vol 38 (9) ◽  
pp. 692-693 ◽  
Author(s):  
D A Jones ◽  
D K Pillai ◽  
B J Rathbone ◽  
J B Cookson

BMJ ◽  
1990 ◽  
Vol 300 (6717) ◽  
pp. 82-83 ◽  
Author(s):  
G H Burton

Sign in / Sign up

Export Citation Format

Share Document